Skip to main content
Clinical Trials/NCT02003846
NCT02003846
Completed
Not Applicable

Comparing the Effects of Bubble Nasal CPAP Versus Ventilator Nasal CPAP in Preterm Infants

Maimonides Medical Center1 site in 1 country18 target enrollmentNovember 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Respiratory Distress Syndrome
Sponsor
Maimonides Medical Center
Enrollment
18
Locations
1
Primary Endpoint
Physiologic parameters
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

There are various methods to generate the pressure needed for Nasal CPAP. Some neonatal intensive care units (NICU) use an underwater bubbling system and others use a ventilator to generate the pressure. There is no right or wrong way to generate the pressure and both methods are approved and accepted.

The aim of this study is to compare the two systems of Nasal CPAP by placing the baby on each for a defined time period and reviewing the infant's vital signs. The investigators expect that the pressure generated by bubble CPAP will be better and lead to improved vital signs.

Detailed Description

There are various methods to generate the pressure needed for Nasal CPAP. Some neonatal intensive care units (NICU) use an underwater bubbling system and others use a ventilator to generate the pressure. There is no right or wrong way to generate the pressure and both methods are approved and accepted. The aim of this study is to compare the two systems of Nasal CPAP by placing the baby on each for a defined time period and reviewing the infant's vital signs. The investigators expect that the pressure generated by bubble CPAP will be better and lead to improved vital signs.

Registry
clinicaltrials.gov
Start Date
November 2013
End Date
October 2014
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Shantanu Rastogi

Attending Neonatologist

Maimonides Medical Center

Eligibility Criteria

Inclusion Criteria

  • Neonates between 26-32 weeks gestational age who have been on Nasal CPAP for at least 48hrs on fraction of inspired oxygen (FiO2) of \< or = 0.
  • Parental consent will be obtained prior to enrollment.

Exclusion Criteria

  • Infants with severe congenital anomalies, such as airway or chest wall deformities, pulmonary hypoplasia, congenital heart disease, neurologic abnormalities including severe intraventricular hemorrhage (IVH) and need for surgery eg. for necrotizing enterocolitis will be excluded from the study. Any infants with genetic/chromosomal abnormalities will be excluded.

Outcomes

Primary Outcomes

Physiologic parameters

Time Frame: 2 hours

heart rate, respiratory rate, oxygen saturation

Secondary Outcomes

  • Physiologic parameters(2 hours)

Study Sites (1)

Loading locations...

Similar Trials